A series of pyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[4,3-c]pyrimidines
were prepared via oxidative cyclization of 4-(2-arylidenehydrazinyl)pyrido
[3',2':4,5]thieno[3,2-d] pyrimidines. Dimroth rearrangement of such a series
yielded pyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines. The
reaction mechanism was proposed and the products were screened for their
antimicrobial and anticancer activities. From the antimicrobial screening
results, it can be seen that compounds 8c, 9f and 10c showed excellent
activity against gram positive bacteria while compounds 10d and 8c showed the
highest activity against gram negative bacteria. The results of the
anticancer activities showed that compound 9c was the most active against
HepG-2 and MCF-7 with IC50 values of 1.19 and 3.46, respectively.